NCT04064268View on ClinicalTrials.gov

Anabolic Potential of 3-hydroxybutyrate (3-OHB) and Whey Protein in a Human Catabolic Inflammatory Disease Model

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 17, 2019

Primary Completion Date

January 23, 2020

Study Completion Date

January 23, 2020

Conditions
EndotoxemiaMuscle LossCatabolic StateProtein; DiseaseNutrition Therapy
Interventions
DIETARY_SUPPLEMENT

Whey

45 g whey + 20 g maltodextrin

DIETARY_SUPPLEMENT

3-OHB + Whey

50 g ketone + 45 g whey + 20 g maltodextrin

Trial Locations (1)

8000

Medical Research Laboratory, DoH, Aarhus University Hospital, Aarhus

All Listed Sponsors
collaborator

Arla Foods Ingredients

UNKNOWN

collaborator

Aarhus University Hospital

OTHER

lead

University of Aarhus

OTHER

NCT04064268 - Anabolic Potential of 3-hydroxybutyrate (3-OHB) and Whey Protein in a Human Catabolic Inflammatory Disease Model | Biotech Hunter | Biotech Hunter